Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022

SELL
$86.42 - $109.81 $715,471 - $909,116
-8,279 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$98.56 - $119.91 $170,410 - $207,324
1,729 Added 26.4%
8,279 $892,000
Q3 2021

Nov 15, 2021

BUY
$91.91 - $110.37 $244,940 - $294,136
2,665 Added 68.6%
6,550 $717,000
Q2 2021

Aug 10, 2021

BUY
$86.24 - $95.92 $335,042 - $372,649
3,885 New
3,885 $364,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Dcm Advisors, LLC Portfolio

Follow Dcm Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dcm Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dcm Advisors, LLC with notifications on news.